Statements of Cash Flows - USD ($)	1 Months Ended	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (7,267)	$ (322,270)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative warrant liabilities		(452,450)
Financing cost - derivative warrant liabilities		314,650
General and administrative expenses paid by Sponsor through note payable	6,267	24,589
Gain on investments held in Trust Account		(35,907)
Changes in operating assets and liabilities:
Prepaid expenses		(184,299)
Accounts payable		25,294
Franchise tax payable		217,534
Accrued expenses	1,000	13,000
Net cash used in operating activities		(399,859)
Cash Flows from Investing Activities
Cash deposited in Trust Account		(116,725,000)
Net cash used in investing activities		(116,725,000)
Cash Flows from Financing Activities:
Repayment of note payable to Sponsor		(108,226)
Proceeds received from initial public offering, gross		115,000,000
Proceeds received from private placement		5,525,000
Offering costs paid		(2,584,078)
Net cash provided by financing activities		117,832,696
Net increase in cash		707,837
Cash - beginning of the period
Cash - end of the period		707,837
Supplemental disclosure of noncash activities:
Offering costs paid in exchange for Founder Shares	25,000
Offering costs paid through note payable to Sponsor		77,370
Offering costs included in accrued expenses		75,000
Deferred underwriting commissions in connection with the initial public offering		4,025,000
Accretion of Class A common stock to redemption amount		$ 13,383,298